US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIOHARVEST SCIENCES INC

9.00

-0.0400-0.44%

Volume:5.64K

Turnover:50.34K

Market Cap:156.00M

PE:-12.93

High:9.07

Open:8.70

Low:8.70

Close:9.04

52wk High:9.90

52wk Low:4.72

Shares:17.33M

Float Shares:12.49M

Volume Ratio:0.30

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6959

EPS(LYR):-0.7974

ROE:-973.22%

ROA:-16.70%

PB:-36.94

PE(LYR):-11.29

Loading ...

Overview Company News Filings

BioHarvest Sciences Second Quarter 2025 Earnings: EPS Misses Expectations

Simply Wall St.

BioHarvest Sciences (BHST) Gets a Buy from Craig-Hallum

Bioharvest Sciences Inc reports results for the quarter ended June 30 - Earnings Summary

BioHarvest Sciences (BHST) Gets a Buy from Craig-Hallum

BioHarvest Sciences Inc. - Common Stock Q2 EPS $(0.24) Misses $(0.06) Estimate, Sales $8.515M Miss $13.785M Estimate

Calendar of U.S. Earnings Expected in the Week Ahead

Bioharvest Sciences Inc expected to post a loss of 11 cents a share - Earnings Preview

BioHarvest Sciences Inc. Releases Pre-Close Brief Ahead of August 11, 2025, Earnings Call to Discuss Q2 Financial Results

Bioharvest Sciences Inc. Conducted Annual General and Special Meeting of Shareholders

Bioharvest Sciences Inc. Concluded Annual General and Special Meeting

Bioharvest Sciences Inc. Unveils Informed Sport-Certified VINIA DailyChews 2X Formula to Boost Athletic Performance and Blood Flow

BioHarvest Secures Contract to Develop Plant-Based Fragrance Using AI and Botanical Synthesis

BioHarvest Sciences Reports 47% Increase in Q1 2025 Revenues to $7.9 Million, Surpassing Guidance

BioHarvest Sciences Inc. - Common Stock Q1 EPS $(0.13), Inline, Sales $7.86M Miss $11.93M Estimate

BioHarvest Sciences Advances CDMO Contract to Stage 2 with Nasdaq-Listed Pharma Company

BioHarvest Sciences initiated with a Buy at Craig-Hallum

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock?

Kymera Therapeutics (KYMR) Moves 13.8% Higher: Will This Strength Last?

BioHarvest Sciences Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BHST/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BHST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BHST\",,,,,undefined,":{"symbol":"BHST","market":"US","secType":"STK","nameCN":"BIOHARVEST SCIENCES INC","latestPrice":9,"timestamp":1755887409067,"preClose":9.04,"halted":0,"volume":5644,"delay":0,"floatShares":12493703,"shares":17333431,"eps":-0.695904,"marketStatus":"Trading","change":-0.04,"latestTime":"08-22 14:57:18 EDT","open":8.7,"high":9.0747,"low":8.7,"amount":50338.32804,"amplitude":0.041449,"askPrice":9.05,"askSize":3806,"bidPrice":8.8,"bidSize":17,"shortable":3,"etf":0,"ttmEps":-0.695904,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1755892800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":9.04,"postHourTrading":{"tag":"盘后","latestPrice":9.1,"preClose":9.1,"latestTime":"16:28 EDT","volume":26,"amount":239.54,"timestamp":1755808099347},"volumeRatio":0.302959},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BHST\",,,,,undefined,":{"symbol":"BHST","floatShares":12493703,"roa":"-16.70%","roe":"-973.22%","lyrEps":-0.797404,"volumeRatio":0.302959,"shares":17333431,"dividePrice":0,"high":9.0747,"amplitude":0.041449,"preClose":9.04,"low":8.7,"week52Low":4.7237,"pbRate":"-36.94","psRate":"5.17","week52High":9.8975,"institutionHeld":0,"latestPrice":9,"committee":-0.991106,"eps":-0.695904,"divideRate":0,"volume":5644,"delay":0,"ttmEps":-0.695904,"open":8.7,"prevYearClose":6.18,"prevWeekClose":9.3235,"prevMonthClose":7.6,"prevQuarterClose":6.73,"fiveDayClose":9.3235,"twentyDayClose":7.58,"sixtyDayClose":6.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BHST\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-11","symbol":"BHST","fiscalQuarterEnding":"2025/06","expectedEps":-0.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2025-05-15","symbol":"BHST","fiscalQuarterEnding":"2025/03","expectedEps":-0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-03-31","symbol":"BHST","fiscalQuarterEnding":"2024/12","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2024-11-25","symbol":"BHST","fiscalQuarterEnding":"2024/09","expectedEps":-0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1732510800000,"reportTimeType":"post","actualEps":-0.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BHST\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BHST\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1746504000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BHST\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BHST","date":"2025-08-21","current":-13.281923,"percent":0.267016,"low":-17.634717,"twenty":-13.782231,"median":-7.341435,"eighty":-5.985809,"high":-4.869221,"avg":-9.103291,"sd":3.736677,"marketCap":160219836},"quantilePoints":[{"date":"2024-11-15","current":-6.399593,"twenty":-6.399593,"median":-6.399593,"eighty":-6.230275,"marketCap":103865403.61},{"date":"2024-11-22","current":-6.578535,"twenty":-6.670268,"median":-6.505104,"eighty":-6.399593,"marketCap":106769625.28},{"date":"2024-11-29","current":-6.258648,"twenty":-6.636081,"median":-6.415633,"eighty":-6.252153,"marketCap":107598684.56},{"date":"2024-12-06","current":-5.919619,"twenty":-6.587677,"median":-6.266885,"eighty":-6.160277,"marketCap":101770093.44},{"date":"2024-12-13","current":-6.394276,"twenty":-6.549163,"median":-6.254589,"eighty":-6.178912,"marketCap":109930392.21},{"date":"2024-12-20","current":-6.319174,"twenty":-6.425257,"median":-6.250529,"eighty":-6.161351,"marketCap":108639237.75},{"date":"2024-12-27","current":-6.085853,"twenty":-6.399593,"median":-6.236881,"eighty":-6.142323,"marketCap":104627983.18},{"date":"2025-01-03","current":-6.14327,"twenty":-6.399593,"median":-6.232093,"eighty":-6.143081,"marketCap":105615097.28},{"date":"2025-01-10","current":-6.158969,"twenty":-6.396403,"median":-6.227192,"eighty":-6.142891,"marketCap":105884985.66},{"date":"2025-01-17","current":-5.951235,"twenty":-6.349215,"median":-6.186337,"eighty":-6.122214,"marketCap":102313635.51},{"date":"2025-01-24","current":-5.363116,"twenty":-6.317967,"median":-6.163655,"eighty":-6.097645,"marketCap":92202685.6},{"date":"2025-01-31","current":-5.043213,"twenty":-6.296448,"median":-6.158356,"eighty":-5.955891,"marketCap":86702920.34},{"date":"2025-02-07","current":-5.636086,"twenty":-6.26359,"median":-6.152222,"eighty":-5.700475,"marketCap":96895588.66},{"date":"2025-02-14","current":-5.636635,"twenty":-6.257248,"median":-6.14327,"eighty":-5.662603,"marketCap":96905033.24},{"date":"2025-02-21","current":-5.352019,"twenty":-6.254224,"median":-6.142323,"eighty":-5.638701,"marketCap":92011910},{"date":"2025-02-28","current":-5.232483,"twenty":-6.250215,"median":-6.121412,"eighty":-5.636086,"marketCap":89956842},{"date":"2025-03-07","current":-5.233692,"twenty":-6.246545,"median":-6.107216,"eighty":-5.388668,"marketCap":89977636},{"date":"2025-03-14","current":-5.230971,"twenty":-6.236154,"median":-6.085853,"eighty":-5.363255,"marketCap":89930851},{"date":"2025-03-21","current":-6.439134,"twenty":-6.236154,"median":-6.085853,"eighty":-5.365464,"marketCap":110701585},{"date":"2025-03-28","current":-6.500918,"twenty":-6.257948,"median":-6.110985,"eighty":-5.373286,"marketCap":111763774},{"date":"2025-04-04","current":-7.7024,"twenty":-6.306302,"median":-6.125426,"eighty":-5.388668,"marketCap":99461095},{"date":"2025-04-11","current":-7.447443,"twenty":-6.399593,"median":-6.142797,"eighty":-5.431083,"marketCap":96168829},{"date":"2025-04-17","current":-7.541375,"twenty":-6.500918,"median":-6.146873,"eighty":-5.432046,"marketCap":97381769},{"date":"2025-04-25","current":-8.856418,"twenty":-6.64761,"median":-6.15668,"eighty":-5.543418,"marketCap":114362932},{"date":"2025-05-02","current":-8.923513,"twenty":-6.803286,"median":-6.161237,"eighty":-5.608487,"marketCap":115229318},{"date":"2025-05-09","current":-8.681974,"twenty":-7.436708,"median":-6.168312,"eighty":-5.636086,"marketCap":112110328},{"date":"2025-05-16","current":-8.628299,"twenty":-7.527956,"median":-6.19099,"eighty":-5.636086,"marketCap":111417220},{"date":"2025-05-23","current":-12.291287,"twenty":-7.795929,"median":-6.201241,"eighty":-5.636635,"marketCap":106565459},{"date":"2025-05-30","current":-12.691004,"twenty":-8.282093,"median":-6.232093,"eighty":-5.644898,"marketCap":110031002},{"date":"2025-06-06","current":-13.750253,"twenty":-8.588901,"median":-6.237873,"eighty":-5.685074,"marketCap":119214692},{"date":"2025-06-13","current":-15.313345,"twenty":-8.665549,"median":-6.250529,"eighty":-5.700164,"marketCap":132766700},{"date":"2025-06-20","current":-13.890154,"twenty":-8.767855,"median":-6.258648,"eighty":-5.723085,"marketCap":120427633},{"date":"2025-06-27","current":-13.590366,"twenty":-8.856418,"median":-6.291521,"eighty":-5.773211,"marketCap":117828475},{"date":"2025-07-03","current":-13.790225,"twenty":-10.88422,"median":-6.356725,"eighty":-5.805491,"marketCap":119561247},{"date":"2025-07-11","current":-14.429771,"twenty":-12.506135,"median":-6.399593,"eighty":-5.849356,"marketCap":125106116},{"date":"2025-07-18","current":-13.808811,"twenty":-12.858885,"median":-6.470026,"eighty":-5.905556,"marketCap":119722395},{"date":"2025-07-25","current":-15.688879,"twenty":-13.362528,"median":-6.589963,"eighty":-5.932265,"marketCap":136022578},{"date":"2025-08-01","current":-15.189233,"twenty":-13.626341,"median":-6.666492,"eighty":-5.955891,"marketCap":131690649},{"date":"2025-08-08","current":-16.188325,"twenty":-13.739701,"median":-6.764381,"eighty":-5.970971,"marketCap":140352774},{"date":"2025-08-15","current":-13.244707,"twenty":-13.774236,"median":-6.924132,"eighty":-5.984084,"marketCap":159770900},{"date":"2025-08-21","current":-13.281923,"twenty":-13.782231,"median":-7.341435,"eighty":-5.985809,"marketCap":160219836}],"updateTime":1755889038412},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BHST\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559427989","title":"BioHarvest Sciences Second Quarter 2025 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2559427989","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559427989?lang=en_us&edition=fundamental","pubTime":"2025-08-16 03:06","pubTimestamp":1755284781,"startTime":"0","endTime":"0","summary":"NasdaqGM:BHST 1 Year Share Price vs Fair Value Explore BioHarvest Sciences's Fair Values from the Community and select...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/5122000-choice1-main-header/1585186630654","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5122000-choice1-main-header/1585186630654"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/household/nasdaq-bhst/bioharvest-sciences/news/bioharvest-sciences-second-quarter-2025-earnings-eps-misses","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BHST"],"gpt_icon":0},{"id":"2559912668","title":"BioHarvest Sciences (BHST) Gets a Buy from Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2559912668","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559912668?lang=en_us&edition=fundamental","pubTime":"2025-08-15 21:36","pubTimestamp":1755264968,"startTime":"0","endTime":"0","summary":"In a report released today, Matt Hewitt from Craig-Hallum reiterated a Buy rating on BioHarvest Sciences, with a price target of $15.00. The compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bioharvest-sciences-bhst-gets-a-buy-from-craig-hallum-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bioharvest-sciences-bhst-gets-a-buy-from-craig-hallum-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2559252896","title":"Bioharvest Sciences Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559252896","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559252896?lang=en_us&edition=fundamental","pubTime":"2025-08-13 01:45","pubTimestamp":1755020709,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc reports results for the quarter ended June 30 - Earnings SummaryBioharvest Sciences Inc 8MV0.MU reported a quarterly adjusted loss of 24 cents per share for the quarter ended J","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL8N3U41LV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2558636826","title":"BioHarvest Sciences (BHST) Gets a Buy from Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2558636826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558636826?lang=en_us&edition=fundamental","pubTime":"2025-08-11 20:58","pubTimestamp":1754917090,"startTime":"0","endTime":"0","summary":"In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on BioHarvest Sciences. The company’s shares closed last Friday a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bioharvest-sciences-bhst-gets-a-buy-from-craig-hallum-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bioharvest-sciences-bhst-gets-a-buy-from-craig-hallum-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2558165273","title":"BioHarvest Sciences Inc. - Common Stock Q2 EPS $(0.24) Misses $(0.06) Estimate, Sales $8.515M Miss $13.785M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2558165273","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558165273?lang=en_us&edition=fundamental","pubTime":"2025-08-11 19:34","pubTimestamp":1754912060,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. - Common Stock (NASDAQ:BHST) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.06) by 300 percent. This is a 500 percent decrease over losses of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47027345/bioharvest-sciences-inc-common-stock-q2-eps-0-24-misses-0-06-estimate-sales-8-515m-miss-13-785m-est","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2558365911","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2558365911","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558365911?lang=en_us&edition=fundamental","pubTime":"2025-08-11 18:00","pubTimestamp":1754906400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·AMC Ent Hldgs                                    2Q      (.07)  4:15 PM. ·Barrick Mining Corp                                2Q       .46   6:00 AM. ·Gaia Inc. Class A                               2Q      (.08)  4:05 PM. ·Green Plains Inc.                               2Q      (.33)  6:55 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","CAVA","GRWG","FNV","ALXO","GRDN","ARCT","RAL","EE","AIOT","INR","DDD","ACXP","CE","CEVA","PFLT","BHST","PNNT","COYA","AVXL","ARIS","BTM","CAE","BTAI","BW","GAIA","LPSN","ASRT","CAI","TLS","NGS","RPAY","BKV","PAL","HPK","DEC","MRCY","ARQ","MNDY","CAH","EDRY","BITF","MRVI","DSP","IHRT","RNA","LAR","RUM","BLDP"],"gpt_icon":1},{"id":"2557457308","title":"Bioharvest Sciences Inc  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557457308","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557457308?lang=en_us&edition=fundamental","pubTime":"2025-08-08 23:16","pubTimestamp":1754666180,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc <8MV0.MU> expected to post a loss of11cents a share - Earnings Preview Bioharvest Sciences Inc 8MV0.MU  is expected to  report resultson August 11 for the period ending June 30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U02PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2557316986","title":"BioHarvest Sciences Inc. Releases Pre-Close Brief Ahead of August 11, 2025, Earnings Call to Discuss Q2 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557316986","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557316986?lang=en_us&edition=fundamental","pubTime":"2025-08-06 02:37","pubTimestamp":1754419077,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc., a leader in Botanical Synthesis technology, has announced plans to release its financial results for the second quarter ending June 30, 2025. The results will be published before market open on August 11, 2025. Following the release, the company will host a conference call and webcast at 8:00 a.m. Eastern Time on the same day to discuss the financial performance, provide a corporate update, and hold a Q&A session. Interested parties can join the call using the provided dial-in numbers or access the webcast online. A replay of the call will be available until August 25, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief v","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL6zctjx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2549557701","title":"Bioharvest Sciences Inc. Conducted Annual General and Special Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2549557701","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549557701?lang=en_us&edition=fundamental","pubTime":"2025-07-08 04:08","pubTimestamp":1751918922,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc. held its annual general and special meeting of shareholders on June 26, 2025. Shareholders approved all motions put forth, including the election of directors and the appointment of Ziv Haft, Certified Public Accountants , a BDO Member Firm, as auditors. Additionally, the Company's Equity Incentive Compensation Plan was confirmed and approved, replacing the previous Stock Option and Equity Incentive Plans. A special resolution to amend the existing articles to create a staggered board was also passed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system oper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDL4S6C9K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2548383304","title":"Bioharvest Sciences Inc. Concluded Annual General and Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2548383304","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548383304?lang=en_us&edition=fundamental","pubTime":"2025-07-03 22:43","pubTimestamp":1751553811,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. held its annual general and special meeting of shareholders on June 26, 2025. Shareholders approved all motions put forth, including amending the existing articles of the Company to divide the board of directors into three classes with staggered terms. Jake Fiddick and Anne Binder were elected as Class I directors, David Tsur and Sharon Malka as Class II directors, and Zaki Rakib and Vivien Rakib as Class III directors. The appointment of Ziv Haft, Certified Public Accountants , a BDO Member Firm, as auditors was approved. The Company's Equity Incentive Compensation Plan was also confirmed and approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nNDL2mR8F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2540050430","title":"Bioharvest Sciences Inc. Unveils Informed Sport-Certified VINIA DailyChews 2X Formula to Boost Athletic Performance and Blood Flow","url":"https://stock-news.laohu8.com/highlight/detail?id=2540050430","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540050430?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:01","pubTimestamp":1749034882,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc. Unveils Informed Sport-Certified VINIA DailyChews 2X Formula to Boost Athletic Performance and Blood Flow. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via Newsfile  on June 04, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL7ZGYQh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2537293823","title":"BioHarvest Secures Contract to Develop Plant-Based Fragrance Using AI and Botanical Synthesis","url":"https://stock-news.laohu8.com/highlight/detail?id=2537293823","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537293823?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:31","pubTimestamp":1747830665,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. has announced a new contract through its Botanical Synthesis CDMO Services division to develop a plant-based fragrance compound. The agreement, which includes milestone-based payments and a non-disclosure agreement for Stage 1, expands BioHarvest's platform into the fragrance market. Utilizing its advanced AI-assisted research capabilities, the company identified specific plant species to develop a cell bank for efficient production of fragrance molecules. Stage 1 will use BioHarvest's proprietary Botanical Synthesis platform to replicate and multiply the plant's targeted cells. A successful outcome could lead to Stage 2, involving production in liquid media, paving the way for future manufacturing. CEO Ilan Sobel highlighted the contract as validation of the platform's ability to deliver scalable solutions while conserving threatened plant species.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL7CMSjM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2535680390","title":"BioHarvest Sciences Reports 47% Increase in Q1 2025 Revenues to $7.9 Million, Surpassing Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2535680390","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535680390?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:51","pubTimestamp":1747342277,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc., a company specializing in Botanical Synthesis technology, reported a significant increase in its first quarter 2025 financial results. Revenues surged by 47% year-over-year to $7.9 million, surpassing management's guidance. This growth was primarily driven by the success of the VINIA product line, which expanded its active subscriber base to over 50,000 as of February 2025. Gross profit for the quarter rose by 53% to $4.6 million, representing 58.5% of total revenue, compared to $3.0 million or 56.2% in the same period the previous year. The improvement in gross margin was attributed to enhanced manufacturing scale and yields. Looking forward, BioHarvest anticipates continued expansion in its Products and Services business units, aiming to grow the \"VINIA inside\" product lines and subscriber bases, along with adding new CDMO partners. The company remains focused on leveraging its Botanical Synthesis platform to meet rising global consumer health and wellness t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL6x5W0x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2535870611","title":"BioHarvest Sciences Inc. - Common Stock Q1 EPS $(0.13), Inline, Sales $7.86M Miss $11.93M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535870611","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535870611?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:11","pubTimestamp":1747339876,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. - Common Stock Q1 EPS $(0.13), Inline, Sales $7.86M Miss $11.93M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45451679/bioharvest-sciences-inc-common-stock-q1-eps-0-13-inline-sales-7-86m-miss-11-93m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2535781719","title":"BioHarvest Sciences Advances CDMO Contract to Stage 2 with Nasdaq-Listed Pharma Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2535781719","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535781719?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:23","pubTimestamp":1747081431,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. has announced the successful completion of Stage 1 in its CDMO contract with a Nasdaq-listed pharmaceutical company, marking a significant milestone in the development of a novel plant-based compound. The completion of this stage validates the company's proprietary Botanical Synthesis platform, which effectively isolated and multiplied target plant cells to develop active pharmaceutical compounds. Moving forward to Stage 2, BioHarvest will focus on scaling biomass and refining compound concentration to meet commercial production demands. This progress underscores the platform's versatility and enhances BioHarvest's analytical capabilities for future projects.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL90Wz7N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2533853795","title":"BioHarvest Sciences initiated with a Buy at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2533853795","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533853795?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:41","pubTimestamp":1746445282,"startTime":"0","endTime":"0","summary":"Craig-Hallum initiated coverage of BioHarvest Sciences (BHST) with a Buy rating and $15 price target Published first on TheFly – the ultimate sourc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioharvest-sciences-initiated-with-a-buy-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioharvest-sciences-initiated-with-a-buy-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2532074772","title":"BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2532074772","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532074772?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:30","pubTimestamp":1746102600,"startTime":"0","endTime":"0","summary":"Rehovot, Israel-- - BioHarvest Sciences Inc.   , a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the first quarter ended March 31, 2025 after market close on Thursday, May 15, 2025.Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on Thursday, May 15, 2025 to discuss the Company's first quarter 2025 financial results, provide a corporate update, and conclude with a question-and-answer session from telephone participants. To participate, please use the following information:. First Quarter 2025 Earnings Conference CallDate: Thursday, May 15, 2025Time: 4:30 p.m. Eastern timeU.S./Canada Dial-in: 1-877-300-8521International Dial-in: 1-412-317-6026Conference ID: 2552254Webcast: BHST Q1 2025 Earnings Conference Call. Please dial in at least 10 minutes before the start of the call to ensure timely participation.A telephone playback of the call will be available through Th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-sciences-host-first-quarter-123000420.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-host-first-quarter-123000420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EML","HST","BHST"],"gpt_icon":0},{"id":"2527419189","title":"BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527419189","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527419189?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:20","pubTimestamp":1744716000,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. BHST shares ended the last trading session 5.2% higher at $5.90. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 4.1% loss over the past four weeks.The rise in share price is attributable to positive investor sentiment around the company’s proprietary technology platform to grow plant-based molecules, without the need to grow the underlying plant.This company is expected to post quarterly loss of $0.15 per share in its upcoming report, which represents a year-over-year change of +57.1%. Revenues are expected to be $7.75 million, up 45.1% from the year-ago quarter.BioHarvest Sciences Inc. belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Apellis Pharmaceuticals, Inc. APLS, closed the last trading session 0.5% lower at $19.33. Over the past month, APLS has returned -21.3%.BioHarvest Sciences Inc.  : Free Stock Analysis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-inc-bhst-soars-112000604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756325.SGD","BK4585","BK4588","BHST","BK4139","BK4505","APLS","BK4183","LU1093756168.USD"],"gpt_icon":0},{"id":"2526516775","title":"Kymera Therapeutics (KYMR) Moves 13.8% Higher: Will This Strength Last?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526516775","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526516775?lang=en_us&edition=fundamental","pubTime":"2025-04-10 22:10","pubTimestamp":1744294200,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics, Inc.  shares ended the last trading session 13.8% higher at $23.95. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 36.7% loss over the past four weeks.Shares rallied due to broader market optimism following President Trump's tweet that there would be a 90-day pause on reciprocal tariffs for non-retaliating countries. Kymera also announced the appointment of Noah Goodman as its new Chief Business Officer.For Kymera Therapeutics, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on KYMR going forward to see if this recent jump can turn into more strength down the road.Kymera Therapeutics is a member of the Zacks Medical - Biomedical and Genetics industry. One other stock in the same industry, B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kymera-therapeutics-kymr-moves-13-141000475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BHST","BK4183","BK4139","KYMR"],"gpt_icon":0},{"id":"2525063860","title":"BioHarvest Sciences Price Target Maintained With a $14.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2525063860","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525063860?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:00","pubTimestamp":1744110000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BHST/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2025 07:00 ET (11:00 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}